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Supplemental information
Supplemental Figure S1 . First in vivo dose of navitoclax resulted in marked ultrastructural changes in CLL cells. CLL cells isolated from two different patients prior to receiving navitoclax and 4 h after the first in vivo dosing during day 1 of the lead-in-period (L1D1) were incubated ex vivo for a further 8 h, before fixation in 2% glutaraldehyde and transmission electron microscopy. CLL cells from patients exposed to navitoclax exhibited chromatin condensation and rupture of the outer mitochondrial membrane. Scale bar -500 nm. 
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